Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 41 Total
ZVRA - Zevra Therapeutics Inc - Stock Price Chart
TickerZVRA [NASD, RUT]
CompanyZevra Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap240.64MEPS (ttm)-1.30
P/E-EPS this Y-1.38%
Forward P/E-EPS next Y88.89%
PEG-EPS past 5Y52.02%
P/S14.53EPS next 5Y-
P/B3.11EPS Q/Q-110.90%
Dividend-Sales Q/Q0.73%
Insider Own8.04%Inst Own30.99%
Insider Trans0.00%Inst Trans-5.59%
Short Float5.59%EarningsMar 28/a
Analyst Recom1.00Target Price17.40
Avg Volume277.89K52W Range3.89 - 7.28
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson ThomasDirectorSep 06 '23Buy4.8810,00048,76410,000Sep 06 04:39 PM
Clifton R. LaDuaneCFO, Secretary & TreasurerSep 06 '23Buy4.961,0004,95915,309Sep 06 05:11 PM
Bode John BDirectorSep 05 '23Buy5.1310,00051,33320,000Sep 06 04:40 PM
Schafer JoshuaCCO & EVP, Bus. DevelopmentSep 05 '23Buy5.135002,5643,500Sep 06 05:11 PM
Watton Corey MichaelDirectorJun 23 '23Buy5.952751,6361,000Jun 26 04:19 PM
12345